Jamie Doone
Physician Assistant · Tampa, FLNPI 1679133847
Payments from drug & device makers
Across 162 payments — averaging $30.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$662
- Astellas Pharma US Inc$549
- Endo Pharmaceuticals Inc.$532
- AbbVie$345
- Ferring Pharmaceuticals Inc.$277
- Teleflex LLC$258
- plus $2K from 30 others
What the payments were for
- Travel & lodging$721%
- Food & beverage$4,54192%
- Education$3046%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 6 | $662 |
| Astellas Pharma US Inc | 19 | $549 |
| Endo Pharmaceuticals Inc. | 22 | $532 |
| AbbVie(2 entities) | 24 | $345 |
| Ferring Pharmaceuticals Inc. | 1 | $277 |
| Teleflex LLC | 6 | $258 |
| Myovant Sciences Inc. | 7 | $226 |
| Angiodynamics, Inc. | 2 | $201 |
| Johnson & Johnson | 7 | $182 |
| Endo USA, Inc. | 2 | $149 |
| Medtronic | 3 | $138 |
| Coloplast | 6 | $136 |
| Axonics, Inc. | 3 | $130 |
| Tolmar Pharmaceuticals, Inc. | 7 | $127 |
| Bayer | 5 | $100 |
| Telix Pharmaceuticals | 3 | $81 |
| Acerus Pharmaceuticals Corporation | 4 | $76 |
| Stryker | 1 | $73 |
| Dendreon Pharmaceuticals LLC | 3 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $69 |
| Tolmar, Inc. | 3 | $65 |
| Antares Pharma, Inc. | 4 | $63 |
| Clarus Therapeutics Inc. | 3 | $51 |
| Novartis | 3 | $49 |
| Pfizer | 2 | $45 |
| Boston Scientific | 2 | $38 |
| Merck | 2 | $37 |
| 180 Medical, Inc. | 1 | $29 |
| Foundation Medicine, Inc. | 1 | $28 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Ambu Inc. | 1 | $23 |
| Urovant Sciences Inc | 1 | $21 |
| Tempus AI, Inc | 1 | $20 |
| Progenics Pharmaceuticals, Inc. | 1 | $16 |
| Mission Pharmacal Company | 1 | $14 |
| Dentsply IH Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$443
- ADSTILADRIN$277
- XIAFLEX$240
- AQUABEAM SYSTEM$173
- Nanoknife$159
- UroLift$139
- ORGOVYX$121
How this compares
$4,916 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 50 | $44,299 |
| GemtesaVibegron | 23 | $24,311 |
| Testosterone Cypionate | 66 | $3,767 |
| Methenamine Hippurate | 36 | $3,503 |
| Estradiol | 46 | $3,052 |
| Tamsulosin Hcl | 213 | $2,537 |
| Testosterone | 19 | $2,253 |
| Potassium Citrate ErPotassium Citrate | 22 | $1,217 |
| Cefpodoxime Proxetil | 33 | $939 |
| Finasteride | 73 | $860 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $788 |
| Oxybutynin Chloride ErOxybutynin Chloride | 28 | $609 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $321 |
| Terazosin Hcl | 11 | $270 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $81 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $549 | $44,29950 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $69 | $24,31123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Tampa
- Kevin WilliamsTampa$647K
- Grace DoyleTampa$123K
- Kevin AllisonTampa$88K
- Tiffany ValoneTampa$62K
- David JohnsonTampa$51K
- Kimberly SidersTampa$47K
- Jaime ApplefieldTampa$39K
- Kenneth BoccaccioTampa$31K
- Mark HonorTampa$30K
- Richard MarshallPort Orange$988K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.